OVERVIEW

2021 American Society of Pediatric Hematology/Oncology (ASPHO) Conference is organized by American Society of Pediatric Hematology-Oncology (ASPHO) and will be held from Apr 20 - 23, 2021.

Accreditation:
The American Society of Pediatric Hematology/Oncology designates this live activity for a maximum of 37 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC)
ASPHO offers a Maintenance of Certification (MOC) opportunity in the form of an Online MOC Post-Test. The online MOC Post-Test includes faculty written case-based, multiple-choice questions based on the educational sessions. Attendees will receive 10 MOC Part 2 points upon completion of the test questions and a 70% minimum score. When purchased, attendees will be able to access the questions online as part of the evaluation.

Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 10 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Description:
The flagship meeting for professionals in pediatric hematology/oncology, advancing knowledge, discovery, and collaboration.

Programs benefit professionals from throughout the field:
• Subspecialist investigators and practitioners from every sector of pediatric hematology/oncology
• Hospitalists, physician assistants, advanced nurse practitioners, other advanced practice providers and allied healthcare professionals
• Early, mid- and late-career professionals from the U.S. and abroad
• Medical residents and students wanting advanced subscpecialty knowledge

Topics:
• Challenges of Pediatric Thrombosis
• Cellular Therapy, Gene Editing and Complications of Sickle Cell Disease
• Challenges in Pediatric Transfusion Medicine and the Consequences of Iron Overload
• Toxicities (Including Financial Toxicity) associated with Childhood Cancer Treatment
• Approach to the Patients with Rhabdomyosarcoma and Refractory/Relapsed Sarcoma
• Artificial Intelligence, Machine Learning, and Surveillance to Detect Relapse in Pediatric Patients with Solid Tumors
• Pediatric Lymphoma and Post-Transplant Lymphoproliferative Disorder (PTLD)
• Pediatric Acute Leukemias and Leukemia Predisposition Syndromes
• Genomics of Pediatric Solid Tumors, including CNS Tumors, and Risk-Adapted Therapy for Medulloblastoma
• Emicizumab in Pediatric Patients with Hemophilia A
• Treatment of Neurofibromatosis Type 1 (NF1)- Related Tumors
• Vascular Anomalies Primer
• Immunology and Immunotherapy
• Updates and Opportunities from the FDA for the Pediatric Hematology/Oncology Specialist
• Practical Wellness to Battle Burnout
• Improving Clinic Flow in a Hematology/Oncology Outpatient Practice

Education Objectives:
• Comprehend new information in pediatric hematology/oncology, including the latest in basic and clinical research.
• Apply knowledge gained in all areas of pediatric hematology/oncology investigation and practice.
• Assemble a network of professional colleagues with whom you can solve problems, share experiences, and provide mutual professional support.